National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Fucoidan is a polysaccharide that primarily consists of groups of L-fucose and sulphate. As a result of its promising therapeutic results, Fucoidan is beneficial worldwide, especially in the food and pharmaceutical industries. The special biological structure is ascribed to its applaudable biological roles. Anti-oxidant, anti-tumor, anti-coagulant, anti-thrombotic, immunoregulatory, anti-viral, and anti-inflammatory effects are classic fucoidan-associated bioactivities. More recently, to further emphasise its therapeutic ability, a number of in vitro and in vivo experiments have been performed. This analysis reflects on the advances achieved in discovering the biological activities of fucoidan, which can be useful as a potential treatment. Therefore we have summarised the research performed in vitro and in vivo during the current decade. We expect this review and a variety of others can contribute as a theoretical basis for understanding and inspire further product development of fucoidan.
Citations |
 |
 |
 |
 |
